首页> 外文期刊>CNS spectrums >Remission and recovery associated with lurasidone in the treatment of major depressive disorder with subthreshold hypomanic symptoms (mixed features): post-hoc analysis of a randomized, placebo-controlled study with longer-term extension
【24h】

Remission and recovery associated with lurasidone in the treatment of major depressive disorder with subthreshold hypomanic symptoms (mixed features): post-hoc analysis of a randomized, placebo-controlled study with longer-term extension

机译:与LuraAnidone相关的缓解和恢复治疗主要抑郁症与亚阈值症状(混合特征):随机,安慰剂对照研究后的HOC分析,具有长期延伸

获取原文
获取原文并翻译 | 示例
       

摘要

Objective. This post-hoc analysis assessed rates of symptomatic and functional remission, as well as recovery (combination of symptomatic and functional remission), in patients treated with lurasidone for major depressive disorder (MDD) associated with subthreshold hypomanic symptoms (mixed features).
机译:客观的。 这种后HOC分析评估了症状和功能性缓解的率,以及伴随的患者恢复(症状和功能缓解的结合),患者对与亚阈值症状(混合特征)相关的主要抑郁症(MDD)治疗的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号